by Ryan Schoensee, University of Texas at San Antonio 3D Model of the heart by Dr. Matthew Bramlet. Credit: NIH An interdisciplinary research team at The University of Texas at San Antonio has successfully developed an innovative inhibitor that shows promise in fighting obesity and potentially preventing heart disease. Francis Yoshimoto, an assistant professor in...
by University of Virginia Credit: CC0 Public Domain An unexpected discovery at UVA Cancer Center has allowed scientists to halt the development of small-cell lung cancer in lab mice, and the surprise finding could open the door to a new treatment approach in people. The researchers, led by UVA’s Kwon-Sik Park, Ph.D., and John H. Bushweller, Ph.D.,...
by Gillian Rutherford, University of Alberta Toshifumi Yokota led research to develop and test a new “cocktail” drug that may be beneficial for up to 45 per cent of patients with a common form of muscular dystrophy — a significantly higher proportion than currently available treatments. Credit: University of Alberta Up to 45% of patients...
RIKEN IMAGE: NEPRILYSIN (RED) AND AΒ (GREEN) LEVELS IN THE HIPPOCAMPUS OF ALZHEIMER’S DISEASE MODEL MICE. TOP: CONTROL. BOTTOM: AFTER BEING FED DIAZOXIDE. AFTER DIAZOXIDE TREATMENT, NEPRILYSIN LEVELS INCREASED AND AΒ LEVELS DECREASES. MICE ALSO PERFORMED BETTER ON MEMORY TESTS (NOT SHOWN HERE). CREDIT: RIKEN Researchers at the RIKEN Center for Brain Science (CBS) in...
A potentially game-changing trial involving University of Liverpool researchers has shown how an immunotherapy drug can prolong the life of patients with an aggressive form of eye cancer. The clinical research trial, taking place at The Clatterbridge Cancer Centre, has for the first time shown that a new treatment can improve survival rates in people...
by St. Jude Children’s Research Hospital From bottom left, clockwise: Paper author Stephen White, DPhil, St. Jude Department of Structural Biology and St. Jude Graduate School of Biomedical Sciences; paper author Richard Lee, Ph.D., St. Jude Department of Chemical Biology and Therapeutics; corresponding author Charles Rock, Ph.D., St. Jude Infectious Diseases; and senior author Suzanne Jackowski, Ph.D., formerly...
by Tokyo Medical and Dental University Treatment of osteoarthritis by miRNA introduction. Credit: Department of Systems BioMedicine , TMDU Researchers from Tokyo Medical and Dental University (TMDU) identify a small RNA molecule with the potential to help slow cartilage deterioration in people living with osteoarthritis Osteoarthritis (OA) is a debilitating joint disease that affects millions of...
by Josh Barney, University of Virginia Credit: CC0 Public Domain A drug used to treat certain advanced breast cancers may offer a new treatment option for a deadly blood cancer known as myelofibrosis, new research from UVA Cancer Center suggests. The drug, palbociclib, may be able to prevent the scarring of bone marrow that existing treatments for myelofibrosis cannot. This...
Two leading causes of blindness are age and diabetes. Of course, many people are born blind or lose their sight early due to genetic reasons. However, out of those people who are reading this article and will get blind in the future, age and diabetes-related problems will be the ones to blame. Now scientists at...
by University of Technology, Sydney Seeds from the Nigella sativa plant, better known as the fennel flower. Credit: University of Technology, Sydney A flowering plant native to North Africa and Western Asia could be utilized in the future treatment of COVID-19 infection. The seeds of the plant, Nigella sativa, have been used for centuries as a traditional...
